EmpiRx Health touts savings from value-based approach to behavioral health therapy management

"We published this data to shed light on this mental health tsunami as well as to demonstrate the successful outcomes of a financially aligned healthcare model," said EmpiRx CEO Karthik Ganesh. "Healthcare service providers play a critical role in making appropriate care not only accessible, but affordable to all."

EmpiRx Health saw a significant increase in pharmacy claims for behavioral health therapies but found managing these treatments in a value-based approach can mitigate the costs.

The pharmacy benefit manager saw claims for behavioral health treatments grow 9.4% between 2020 and 2021, according to a new report released Thursday. Utilization of antidepressant medications grew by 12% year over year, and use of treatments for attention-deficit/hyperactivity disorder (ADHD) increased by 20.2%.

However, per claim spend for antidepressants declined by 1.8% between 2020 and 2021, and per claim spend for ADHD drugs decreased by 9.1%, the PBM said.

Read more


Share on linkedin

More Posts

Environmental, Social, and Governance (ESG) Policy

EmpiRx Health believes that Environmental, Social, and Governance (ESG) principles are crucial to developing a resilient healthcare services company whose workforce diversity resembles the clients and patients we serve. These principles are integrated into our operating discipline, reflected in our social and workplace priorities, good corporate governance, and environmental management, and backed by data-driven monitoring and reporting that hold us accountable for successful outcomes.

Read More

Contact Us

Ready to learn about a different way to approach your pharmacy benefits? 

Request our client success case studies.

Fill in your details to receive the EmpiRx Health case studies.

  • This field is for validation purposes and should be left unchanged.